Press release
Biosimilar Insulin Market Access
ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports.
Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure.
The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer entrants Toujeo and Tresiba.
More aggressive payers are excluding branded insulin products in favor of the less expensive biosimilar, forcing switches in existing patient populations.
As such, manufacturers of branded insulin products will need to offer deeper discounts to remain on payers’ formularies and contracts.
For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access
Key Topics Covered in this Research Report
US
• Insights and strategic recommendations
• US payers are adopting a wait-and-see approach for biosimilar Basaglar
• Bibliography
FIVE MAJOR EU MARKETS
• Insights and strategic recommendations
• Uptake of biosimilar insulin varies across EU markets as the EMA does not determine interchangeability
• Physicians and payers have varying views on the interchangeability of biosimilar insulins, but see large opportunities to reduce costs
• Payers use biosimilars to pressure originators on pricing
• Pharmacies continue to procure both biosimilars and originators; dynamic pricing environment observed
• Patient switching requires significant discounts of at least 30%
• Given attractive discounts, payers will use a variety of market access tools to drive Basaglar’s uptake
• Bibliography
To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=35949
About ReportsWorldwide.com
ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.
Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995
abigail@reportsworldwide.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilar Insulin Market Access here
News-ID: 806686 • Views: …
More Releases from ReportsWorldwide
World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence…
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA
ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports.
Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors.
Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that…
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA
ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports.
This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers:
• CommScope/Airvana
• Comba Telecom
• Ericsson
• Huawei Technologies
• Nokia
• SpiderCloud
• ZTE Corporation
This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021.
To view a detailed description and Table of…
More Releases for Basaglar
Basal Insulin Market is Projected to Reach USD 44,659 Million by 2035 | Key Play …
The global basal insulin market is expected to reach USD 44,659 million by 2035, up from USD 18,893 million in 2024. During the forecast period 2025 to 2035, the industry is projected to register at a CAGR of 8.3%, driven by the increasing burden of Type 2 diabetes, patient-friendly once-daily dosing, and advancements in long-acting analogs such as degludec and glargine. Enhanced delivery technologies, robust R&D, and expanding global diabetes…
Basaglar Market Report 2025-2034: Industry Overview, Drivers, And Forecast Analy …
The Basaglar Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Basaglar Market Size and Its Estimated Growth Rate?
In recent years, the Basaglar market size has experienced an XX (HCAGR) growth. The value of this market is projected to ascend from $XX…
Basaglar Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Eme …
Get 15% off on all our 2025 Global Market Reports with code FY25SAVE - Offer valid till March 31st! …
Basaglar Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Eme …
How Will the Basaglar Market Grow, and What Is the Projected Market Size?
In recent times, the Basaglar market has experienced an $XX growth. The market is projected to inflate from a value of $XX million in 2024 to $XX million in 2025, marking a compound annual growth rate (CAGR) of $XX%. The significant growth during the historical phase can be traced back to heightened public and medical consciousness, rising demand…
Bio-similars Insulin Market Insights, Potential Business Strategies, Mergers and …
New York, March 18, 2020: Biosimilars is an organic item intended to have comparable dynamic properties to the one that has been already authorized and has no clinically critical contrasts as far as security and adequacy. Biosimilars insulin is a sort of biosimilars where it is undefined to the reference insulin item and is as of now been affirmed by FDA or authorized. The makers of biosimilars utilize the comparative…
US Antidiabetics Drug Market US Antidiabetics Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Antidiabetics: Regimen for Diabetes Mellitus
1.1 Prologue Towards Diabetes
1.2 Preface to Antidiabetics
Antiquity of Managing Diabetes Mellitus
2.1 Trajectory from Diabetes to Insulin
2.2 Historical En Route towards Oral Diabetic Medication
Treatments Available for Diabetes Mellitus
3.1 Non-Pharmacological Approaches for Diabetes Mellitus
3.2 Pharmacological Approaches for Diabetes Mellitus
Cataloguing of Antidiabetic Agents
4.1…
